Literature DB >> 22325689

Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.

Priyanka Rao, John McCaughan, Mark McCalmont, Colin E Goldsmith, Valerie Hall, B Cherie Millar, Mary-Ann McCann, Damian G Downey, Jacqueline C Rendall, J Stuart Elborn, John E Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22325689     DOI： 10.1016/j.jcf.2012.01.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  4 in total

1.  Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.

Authors:  Gerard McCaughey; Deirdre F Gilpin; Thamarai Schneiders; Lucas R Hoffman; Matt McKevitt; J Stuart Elborn; Michael M Tunney
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

2.  Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis.

Authors:  Henry L Dorkin; Doris Staab; Elisabeth Operschall; Jeff Alder; Margarita Criollo
Journal:  BMJ Open Respir Res       Date:  2015-12-02

3.  Molecular analysis and antimicrobial resistance pattern of distinct strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran.

Authors:  Mohammad Emaneini; Davood Kalantar-Neyestanaki; Leila Jabalameli; Mojtaba Hashemi; Reza Beigverdi; Fereshteh Jabalameli
Journal:  Iran J Microbiol       Date:  2019-04

4.  Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications.

Authors:  Yong-Hua Gao; Wei-Jie Guan; Ya-Nan Zhu; Rong-Chang Chen; Guo-Jun Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.